Delivery Order SPE2DR25D1100-SPE2DR26FCS2J
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order on September 9, 2025, by the Defense Logistics Agency to supply 60 tablets of Eliquis 5 mg for $12,352.75, with final delivery required by September 10, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of the vendor's substantial pharmaceutical supply relationship with the federal government. The order was fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $35,692.53 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Eliquis 5 mg tablets (60-count units). This is a firm fixed-price, competitively awarded contract with an ultimate completion date of December 2, 2025, and represents a child delivery order under AmerisourceBergen's larger contract vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg with a ceiling value of $10,534.14. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 5, 2025, and represents a pharmaceutical supply transaction typical of the company's federal medical procurement activities. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,546.46 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg on December 5, 2025, with completion scheduled for December 8, 2025. This competitively awarded, firm fixed-price contract reflects a small-value pharmaceutical transaction typical of the company's extensive federal medical supply portfolio. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency has awarded a delivery order valued at $7,892.66 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This non-competitive delivery order, issued on December 3, 2025, with an ultimate completion date of December 4, 2025, utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical will be delivered to the company's...
- The Defense Logistics Agency awarded a delivery order valued at $4,208.58 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg on December 1, 2025, with completion scheduled for December 2, 2025. This competitive award, issued under a firm fixed-price contract type with no set-aside designation, represents a small-value pharmaceutical procurement supporting federal medical supply requirements. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,813.50 for 60 tablets of Eliquis 5 mg, with an ultimate completion date of August 15, 2025. This is a firm fixed-price, non-set-aside contract utilizing competitive procurement procedures. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor and healthcare solutions provider. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,533.97 for 60 tablets of Eliquis 5 mg on August 18, 2025, with completion scheduled for August 19, 2025. This is a firm fixed price, non-set-aside contract utilizing a competitive award process. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $1,902.96 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) on December 5, 2025, with a completion date of December 8, 2025. This non-competitive, firm fixed-price delivery order represents a routine pharmaceutical procurement under the company's broader federal contract portfolio. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order valued at $56,984.99 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on November 13, 2025, with completion targeted for November 14, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters and...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCS2JDelivery Order
The Defense Logistics Agency awarded a $23,834.83 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60-tablet units of Eliquis 5 mg on December 2, 2025, with completion scheduled for December 3, 2025. This non-set-aside competitive award represents a pharmaceutical supply delivery to support federal medical procurement needs. The order is being fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major pharmaceutical distributor and healthcare solutions provider. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of medications and medical supplies to military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates consistent capability in fulfilling competitive procurement requirements across multiple therapeutic domains, serving critical customers including the Defense Health Agency and U.S. Coast Guard through flexible contract mechanisms designed to support ongoing military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.8k | 12/1/25 |